Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Could behavioral therapies target specific deficits in multiple sclerosis patients?
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
The Evaluation of the Retinal Nerve Fiber Layer in Multiple Sclerosis with Special-Domain Optical Coherence Tomography.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Diagnosis and classification of autoimmune optic neuropathy.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
Update on neurodegeneration with brain iron accumulation.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Fingolimod (Gilenya) eligibility extended by NHS England
Low serum urate levels are associated to female gender in multiple sclerosis patients.
[Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro].
Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Socioeconomic status. The relationship with health and autoimmune diseases.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Multiple sclerosis as a cause of the acute vestibular syndrome.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »